Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

Abstract Carlson LA, Hamsten A, Asplund A (King Gustaf V Research Institute and Department of Internal Medicine, Karolinska Institute and Karolinska Hospital, Stockholm, Sweden). Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid.

[1]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[2]  B. Philipson,et al.  Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia Clinical and laboratory studies in two afflicted families , 1982, European journal of clinical investigation.

[3]  A. Gotto,et al.  Human plasma lipoprotein [a]. Structural properties. , 1983, The Journal of biological chemistry.

[4]  L. Carlson,et al.  The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. , 2009, Acta medica Scandinavica.

[5]  V. Armstrong,et al.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.

[6]  C. Packard,et al.  Fenofibrate Reduces Low Density Lipoprotein Catabolism in Hypertriglyceridemic Subjects , 1985, Arteriosclerosis.

[7]  G. Hoefler,et al.  Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction , 1988, Arteriosclerosis.

[8]  L. Carlson,et al.  Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. , 2009, Acta medica Scandinavica.

[9]  W. Hazzard,et al.  Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. , 1975, Metabolism: clinical and experimental.

[10]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[11]  A. Olsson,et al.  Effect of hypolipidemic drugs on serum lipoproteins. , 1979, Progress in biochemical pharmacology.

[12]  A. Gotto,et al.  Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B , 1985, Arteriosclerosis.

[13]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[14]  H. Lithell,et al.  Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia. , 1982, Atherosclerosis.

[15]  D. Ballantyne,et al.  On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. , 1977, Atherosclerosis.

[16]  H. Brewer,et al.  Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. , 1985, Atherosclerosis.

[17]  L. Carlson.  Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia Clinical and laboratory studies in two afflicted families , 1982, Lancet.